President Trump Announces 100% Tariffs on Imported Generic Drugs to Reshore Production
President Trump has announced a plan to impose 100% tariffs on imported generic drugs starting in August 2028, with the aim of reshoring pharmaceutical production to the U.S. The tariffs are intended to encourage manufacturers to relocate their operations domestically. However, health policy experts express skepticism about the effectiveness of tariffs alone in achieving this goal. The generic drug industry, which accounts for 90% of U.S. prescriptions, relies heavily on imports from countries like India and China. The plan includes a two-year transition period for manufacturers to adjust their production strategies. 
